Raymond James Financial Services Advisors, Inc. Ocular Therapeutix, Inc Transaction History
Raymond James Financial Services Advisors, Inc.
- $66.3 Billion
- Q1 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 54,184 shares of OCUL stock, worth $370,618. This represents 0.0% of its overall portfolio holdings.
Number of Shares
54,184
Previous 62,040
12.66%
Holding current value
$370,618
Previous $276,000
78.62%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding OCUL
# of Institutions
148Shares Held
123MCall Options Held
185KPut Options Held
507K-
Summer Road LLC West Palm Beach, FL14.4MShares$98.2 Million100.0% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$87.3 Million9.97% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.7MShares$87 Million3.82% of portfolio
-
Black Rock Inc. New York, NY8.06MShares$55.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.24MShares$49.5 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $526M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...